Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.990
-0.020 (-0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed

Biodexa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
274132416
Upgrade
Market Cap Growth
194.10%64.68%-67.88%-43.67%46.08%246.87%
Upgrade
Enterprise Value
-41-39236
Upgrade
Last Close Price
3.9967.007880.0042000.0074800.00137860.00
Upgrade
PS Ratio
7.2514.475.0616.9650.3118.07
Upgrade
PB Ratio
0.131.181.120.942.570.62
Upgrade
P/TBV Ratio
2.513.171.120.942.571.70
Upgrade
EV/Sales Ratio
15.392.20-10.9748.156.85
Upgrade
Debt / Equity Ratio
0.040.100.200.070.040.31
Upgrade
Asset Turnover
0.010.050.080.050.020.03
Upgrade
Quick Ratio
2.161.202.276.063.022.40
Upgrade
Current Ratio
2.161.262.476.393.102.42
Upgrade
Return on Equity (ROE)
-97.23%-180.59%-112.47%-63.60%-168.89%-50.10%
Upgrade
Return on Assets (ROA)
-37.52%-51.38%-51.33%-38.48%-32.76%-27.56%
Upgrade
Return on Capital (ROIC)
-55.03%-92.46%-63.08%-48.07%-40.89%-32.29%
Upgrade
Earnings Yield
-371.85%-128.44%-216.38%-55.70%-128.57%-82.81%
Upgrade
FCF Yield
-421.62%-124.32%-200.95%-64.56%-55.11%-55.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.